Clinical Management Issues (Jun 2010)

A case of beta-thalassaemia major resistant to standard treatment

  • Nicoletta Masera,
  • Valentina Decimi,
  • Luisa Tavecchia,
  • Marietta Capra,
  • Giovanni Cazzaniga,
  • Andrea Biondi,
  • Giuseppe Masera

DOI
https://doi.org/10.7175/cmi.v4i2.531
Journal volume & issue
Vol. 4, no. 2
pp. 65 – 70

Abstract

Read online

We report the case of a 22-year-old woman from Albania, with thalassaemia major, in severe clinical condition who could no longer be transfused due to the occurrence of severe, acute, post-transfusional reactions. After 10 years of treatment, she failed to respond to hydroxyurea. When she received thalidomide, haemoglobin levels increased from 3.7 g/dl to 9 g/dl. Since then, at 22 months of follow-up, the therapy is still effective and well tolerated. The case gives the opportunity to describe the clinical use of thalidomide, and its potential in the management of beta-thalassaemia.

Keywords